Strides Pharma Science Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Dec '23
Sep '23
Jun '23
Mar '23
Dec '22
Total Qtr Revenue cr
1,046.42
1,035.28
938.64
1,013.49
891.05
Other Income Qtr Cr8.7535.858.6527.1226.20
Operating Revenues Qtr1,037.67999.43929.99986.37864.85

*All values are in Cr.

Operating Expenses Qtr
843.86
846.30
763.40
830.81
748.50
Operating Profit Qtr
193.81
153.13
166.59
155.56
116.34
EBIDT Qtr Cr
246.65
24.05
169.26
175.34
184.10
Depreciation Qtr
51.23
60.11
59.59
60.93
60.22
Net Profit Qtr
49.67
-131.34
-7.11
-9.54
-80.03
Basic EPS Qtr
5.43
-14.54
-0.79
-1.06
-8.86
Open Demat Account
or Resume your Application
+91 -

personImage